image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendations

Maintel - £70m of recurring revenue

July 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MAI
  • Price:
  • 250p
Telecoms firm Maintel’s shares are trading at 250p, a far cry from the £11 they hit almost a decade ago. The company’s business has significantly evolved since then and it now appears copper bottomed with its focus on recurring revenue. Given that Maintel supplies communications services for both the private and public sectors, both on-premise and in the cloud, I couldn’t help but think it would be a perfect fit for AdvanvedAdvT (ADVT; 145.5p), especially with its £70m recurring revenue and a cluster of NHS clients. Maintel was founded in 1991 and went public in 2004. The company seems to have had three distinct phases of growth since then. Phase 1: If you had looked at Maintel a decade ago, you would have seen a company focused p ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Maintel (September 2024)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW